Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CPI-006 |
Trade Name | |
Synonyms | CPI 006|CPI006|CPX-006 |
Drug Descriptions |
CPI-006 is a monoclonal antibody against NT5E (CD73) that inhibits the conversion of AMP to adenosine to inhibit tumor growth and also has immunomodulatory activities (Journal of Clinical Oncology 2019 37:15_suppl, TPS2646). |
DrugClasses | Adenosine Targeting 23 CD73 Antibody 12 |
CAS Registry Number | NA |
NCIT ID | C156061 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CPI-006 | CPI-006 | 0 | 1 |
CPI-006 + CPI-444 | CPI-006 CPI-444 | 0 | 1 |
CPI-006 + Pembrolizumab | CPI-006 Pembrolizumab | 0 | 1 |